Finance

Lists
Why is ANTX up 2.48%?
Dive Deeper
ANTX:NASDAQ
AN2 Therapeutics Inc
$4.55
+2.48%
(+0.11) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANTX...
Open
$4.42
High
$4.58
Low
$4.25
Mkt. cap
172.64M
Avg. vol.
298.12K
Volume
205.69K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.94
Shares outstanding
37.94M
No. of employees
21
Open
$4.42
High
$4.58
Low
$4.25
Mkt. cap
172.64M
Avg. vol.
298.12K
Volume
205.69K
52-wk high
$7.19
52-wk low
$1.00
EPS
-$1.07
Beta
-0.94
Shares outstanding
37.94M
No. of employees
21
News stories
From web sources and news partners
About AN2 Therapeutics Inc
CEO-
Employees21
Founded2017
HeadquartersMenlo Park, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
Bradley Canino
Guggenheim
Buy
Initiated
$9.00
+97.8%
07/19/2026
Joseph Schwartz
Leerink Partners
Buy
Upgraded
$9.00
+97.8%
05/15/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
-$0.17 / -$0.20
+15.00%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.88M
6.74M
6.02M
5.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.44M
3.81M
2.88M
2.95M
Operating expense
9.32M
10.55M
8.90M
8.67M
Total operating expenses
9.32M
10.55M
8.90M
8.67M
Operating income
-9.32M
-10.55M
-8.90M
-8.67M
Other non operating income
1.00K
-
-1.00K
-
EBT including unusual items
-8.71M
-10.03M
-8.18M
-7.96M
EBT excluding unusual items
-8.71M
-10.03M
-8.18M
-7.96M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.71M
-10.03M
-8.18M
-7.96M
Net profit margin
-
-
-
-
Earnings per share
-0.29
-0.29
-0.18
-0.17
Interest and investment income
605.00K
523.00K
720.00K
713.00K
Interest expense
-
-
-
-
Net interest expenses
605.00K
523.00K
720.00K
713.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps